XALUPRINE 20 mg/ml, suspension oral bottle, 100 ml
Active ingredients: Mercaptopurine
Commercialized according to BDPMDispensing in France: Prescription only
Suspensionbottle, 100 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XALUPRINE 20 mg/ml, suspension orale
- Pharmaceutical form
- suspension
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre jaune(brun) avec fermeture de sécurité enfant de 100 ml avec 1 adaptateur(s) pour flacon avec 2 seringue(s) pour administration orale
- Marketing authorisation holder
- LIPOMED (ALLEMAGNE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63798857CIP72245740CIP133400922457406Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MERCAPTOPURINE MONOHYDRATÉsuspension | 20 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.